{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:56:49Z","timestamp":1791755809106,"version":"4.3.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1093\/europace\/euj041","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T01:13:11Z","timestamp":1139879591000},"page":"193-198","source":"Crossref","is-referenced-by-count":73,"title":["Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study"],"prefix":"10.1093","volume":"8","author":[{"given":"George N.","family":"Theodorakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionyssios","family":"Leftheriotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios G.","family":"Livanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Flevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Karabela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolitsa","family":"Aggelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios Th.","family":"Kremastinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,2,13]]},"reference":[{"key":"key\n\t\t\t\t20171012075624_EUJ041C1","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0735-1097(01)01621-7","article-title":"Beta-blockers in syncope: the jury is still out.","volume":"38","author":"Sheldon","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.100.11.1242","article-title":"Pharmacotherapy of neurally mediated syncope.","volume":"100","author":"Benditt","year":"1999","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0735-1097(95)00320-7","article-title":"Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.","volume":"26","author":"Cox","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C4","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1540-8167.1996.tb00494.x","article-title":"Response to beta-blockers in patients with neurocardiogenic syncope: how to predict beneficial results.","volume":"7","author":"Natale","year":"1997","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C5","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/eurheartj\/14.11.1499","article-title":"The effectiveness of beta-blockade and its influence on heart rate variability in vasovagal patients.","volume":"14","author":"Theodorakis","year":"1993","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0735-1097(00)01155-4","article-title":"Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.","volume":"37","author":"Madrid","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/0002-8703(95)90150-7","article-title":"Randomized, double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt-table test results.","volume":"130","author":"Mahanonda","year":"1995","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0735-1097(02)01974-5","article-title":"Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.","volume":"40","author":"Flevari","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C9","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1161\/01.CIR.98.24.2724","article-title":"Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge.","volume":"98","author":"Theodorakis","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C10","doi-asserted-by":"crossref","first-page":"3Q","DOI":"10.1016\/S0002-9149(99)00691-8","article-title":"Pathophysiology and differential diagnosis of neurocardiogenic syncope.","volume":"84","author":"Grubb","year":"1999","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0735-1097(94)90308-5","article-title":"The use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents.","volume":"24","author":"Grubb","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0735-1097(98)00694-9","article-title":"Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.","volume":"33","author":"Di Girolamo","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0735-1097(00)00719-1","article-title":"Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.","volume":"36","author":"Theodorakis","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0195-668X(02)00821-7","article-title":"Head-up tilt test with clomipramine challenge in vasovagal syndrome\u2014a new tilt testing protocol.","volume":"24","author":"Theodorakis","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0735-1097(98)00549-X","article-title":"The North American Vasovagal Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.","volume":"33","author":"Connolly","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C16","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/hc3301.094908","article-title":"Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope.","volume":"104","author":"Carey","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.102.3.294","article-title":"Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicenter randomized study.","volume":"102","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C18","first-page":"421","article-title":"Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation.","volume":"46","author":"Dabire","year":"1991","journal-title":"Therapie"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0361-9230(94)00221-L","article-title":"8-OH-DPAT-indused hypotensive action and sympathoexcitatory neurons in the rostal ventrolateral medulla of the rat.","volume":"36","author":"Kubo","year":"1995","journal-title":"Brain Res Bull"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0924-9338(97)80006-5","article-title":"Neuroendocrine responsitivity to clomipramine challenge test in neuroleptic naive psychotic patients before and after treatment with haloperidol.","volume":"12","author":"Angelopoulos","year":"1997","journal-title":"Eur Psychiat"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0006-3223(93)90186-H","article-title":"Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.","volume":"34","author":"Hollander","year":"1993","journal-title":"Biol Psychiat"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C22","first-page":"306","article-title":"Serotonin and syncope: an emerging connection?","volume":"5","author":"Grubb","year":"1995","journal-title":"Eur J Cardiac Pacing Electrophysiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C23","first-page":"9","article-title":"Clinical overview of serotonin reuptake inhibitors.","volume":"51","author":"Rickels","year":"1990","journal-title":"J Clin Psychiat"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/hc2601.091708","article-title":"Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope.","volume":"104","author":"Ammirati","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C25","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1053\/euhj.2000.2577","article-title":"Long-term follow-up of children and adolescents with syncope.","volume":"22","author":"Kouakam","year":"2001","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1046\/j.1460-9592.2002.01441.x","article-title":"Long term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope.","volume":"25","author":"Reybrouck","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0895-4356(91)90005-T","article-title":"Impairment of physical and psychological function in recurrent syncope.","volume":"44","author":"Linzer","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0735-1097(94)00336-O","article-title":"Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo.","volume":"25","author":"Moya","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0002-9149(97)00891-6","article-title":"Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope.","volume":"81","author":"Sheldon","year":"1998","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171012075624_EUJ041C30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/hc3601.095708","article-title":"Mechanism of syncope in patients with isolated syncope and patients with tilt-positive syncope.","volume":"104","author":"Moya","year":"2001","journal-title":"Circulation"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/8\/3\/193\/1469709\/euj041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T12:05:45Z","timestamp":1507809945000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/europace\/article\/8\/3\/193\/553608\/Fluoxetine-vs-propranolol-in-the-treatment-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,13]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,2,13]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euj041","relation":{},"ISSN":["1532-2092","1099-5129"],"issn-type":[{"value":"1532-2092","type":"electronic"},{"value":"1099-5129","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,3]]},"published":{"date-parts":[[2006,2,13]]}}}